NCT01154036
MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)
See it on ClinicalTrials.gov β1,547 people
52.6%
47.4%
813 womenmiddle line = equal numbers734 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2012-10
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 18 Years β 79 Years
- Average age
- Not reported
- Age 65+
- 32.8%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
βFemale patient is pregnant or breastfeedingβ
- No breastfeeding moms
Women who were breastfeeding could not join.
βFemale patient is pregnant or breastfeedingβ
- No kidney or liver problems
Women with kidney or liver problems were turned away.
βPatient has kidney diseaseβ
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
βPatient has congestive heart failureβ
- No diabetes
Women with diabetes were turned away.
βPatient has poorly controlled or newly diagnosed diabetesβ
- No cancer
Women with current or past cancer were turned away.
βPatient has a history of cancer in the last 5 years, except certain skin and cervical cancersβ
Study titles and rules are shown in their original English.